MBL77 - AN OVERVIEW

mutations given The point that, as stated underneath, CLL therapy is based to the existence or absence of such mutations. The current consensus is, in addition to clonal mutations, subclonal mutations with a variant allelic frequency ranging from 5 to ten% (and as a consequence under the edge of detection by conventional molecular techniques) is al